Company Overview
ANI PHARMACEUTICALS INC
ANIPRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
883M
2025 FY
Net Income
78M
2025 FY
Shares Outstanding
20M
2025 FY
EPS
3.5USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1023024
Exchange
Nasdaq
Location
US